Skip to content

Evaluation of Response to CRT

Evaluation of Response to CRT by volumetric Three Dimensional Echocardiography

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20190210042669N1
Enrollment
50
Registered
2019-05-08
Start date
2018-12-22
Completion date
Unknown
Last updated
2019-05-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart failure. Heart failure

Interventions

Intervention group: Patients with CRT candidates with regard to inclusion and exclusion criteria, and based on random numbers table will select. Patients undergo echocardiography before and 2-3 weeks

Sponsors

Deputy of Research of Imam Khomeini Hospital in Ahvaz
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients with heart failure CRT candidates Age over 18 years The attitude to participate in the study NYHA Class III-IV wide QRS and LVEF<35% Sinusoidal rhythm of the EKG The presence of MR in the primary eco

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Quality of life assessment. Timepoint: It will be measured before of intervention and 2 to 3 weeks after the intervention. Method of measurement: Quality of life assessment will be done by using the Minnesota Heart Rate Quality of Life Questionnaire (MLHFQ). This questionnaire contains 21 questions and examines the impact of illness and treatment on the daily life of patients. The questionnaire focuses on symptoms such as dyspnea, fatigue, edema, and the psychological state and the effect of the disease on the daily activities.;Electrocardiography. Timepoint: It will be measured before of intervention and 2 to 3 weeks after the intervention. Method of measurement: Clinical variables including QRS duration (ms), PR interval (ms) and HR (b pm) will be measured by electrocardiogram.Other parameters include LV end-systolic volume (ESV), LV end-diastolic volume (EDV) LV ejection fraction (EF), Mitral Regurgitation (MR), Full-volume of LV will measure by echocardiography.

Secondary

MeasureTime frame
Diabetes. Timepoint: It will be measured before of intervention and 2 to 3 weeks after the intervention. Method of measurement: Parameter of diabetic is measured by glucometer measurement.;Hypertension. Timepoint: It will be measured before of intervention and 2 to 3 weeks after the intervention. Method of measurement: Parameter of hypertension is measured by barometric measurement.;BMI. Timepoint: It will be measured before of intervention and 2 to 3 weeks after the intervention. Method of measurement: Parameter of BMI is measured by scales, weight division by height, measurement.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Sara Shoeibi

Ahvaz University of Medical Sciences

shoeibis901@gmail.com+98 61 3222 2922

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026